Sign in

CIK 0001716166 · Non-accelerated filer<br>Smaller reporting company

Vivos Therapeutics, Inc.

Sign in to watch
Ticker
VVOS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813224056
Phone
(866)908-4867
Business address
7921 SOUTHPARK PLAZA,, SUITE 210, LITTLETON, CO, 80120
Former names
Vivos BioTechnologies, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Chief Executive Officer bought 14,000 shares at $0.53 ($7,420)
  4. 4 Open-market buy Chief Executive Officer bought 15,021 shares at an average $0.54 ($8,061)
  5. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $0.49 ($4,900)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $0.50 ($10,000)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Chief Executive Officer bought 12,000 shares at an average $1.96 ($23,560)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 5 Insider Annual Insider Trading Report
  17. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.31 ($21,550)
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $3.00 ($15,000)
  20. 4 Derivatives Options or other derivatives

Page 2 of 3 · 60 filings